Ftse Mib
34.395,62
0,06%
DAX
18.518,03
-0,44%
S&P 500
5.651,52
0,36%
NASDAQ
18.459,00
-0,07%
Bitcoin
65.113,62
0,40%
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. AMEX BioPharmX Corporation (BPMX) BioPharmX Corporation (BPMX) Notizie

BPMX

BioPharmX (BPMX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:BPMX
DataOraFonteTitoloSimboloCompagnia
23/11/201612:06Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(1) (424b1)AMEX:BPMXBioPharmX Corporation
22/11/201623:13Edgar (US Regulatory)Current Report Filing (8-k)AMEX:BPMXBioPharmX Corporation
22/11/201614:45PR Newswire (US)BioPharmX Corporation Announces Pricing of Unit OfferingAMEX:BPMXBioPharmX Corporation
22/11/201614:00Edgar (US Regulatory)Registration of Additional Securities (up to 20%) (s-1mef)AMEX:BPMXBioPharmX Corporation
22/11/201612:01Edgar (US Regulatory)Notice of Effectiveness (effect)AMEX:BPMXBioPharmX Corporation
18/11/201622:58Edgar (US Regulatory)Securities Registration Statement (s-1/a)AMEX:BPMXBioPharmX Corporation
10/11/201615:00PR Newswire (US)BioPharmX Presents BPX-01 Topical Minocycline Gel Acne Data at SDEF's 17th Annual Las Vegas Dermatology SeminarAMEX:BPMXBioPharmX Corporation
26/10/201615:15PR Newswire (US)BioPharmX Studies Suggest its Violet® Iodine Formulation Inhibits Growth of Both FBC and Common Breast Cancer Cells in vitroAMEX:BPMXBioPharmX Corporation
14/10/201622:12Edgar (US Regulatory)Securities Registration Statement (s-1)AMEX:BPMXBioPharmX Corporation
07/10/201623:01Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)AMEX:BPMXBioPharmX Corporation
27/09/201622:53Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)AMEX:BPMXBioPharmX Corporation
26/09/201622:06Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3/a)AMEX:BPMXBioPharmX Corporation
26/09/201615:00PR Newswire (US)BioPharmX Announces Registered Direct OfferingAMEX:BPMXBioPharmX Corporation
14/09/201623:02Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)AMEX:BPMXBioPharmX Corporation
14/09/201622:18Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)AMEX:BPMXBioPharmX Corporation
14/09/201622:15Edgar (US Regulatory)Quarterly Report (10-q)AMEX:BPMXBioPharmX Corporation
12/09/201622:05PR Newswire (US)BioPharmX Corporation Reports Second Quarter Financial ResultsAMEX:BPMXBioPharmX Corporation
02/09/201614:00PR Newswire (US)BioPharmX to Report Second Quarter Financial Results on September 12, 2016AMEX:BPMXBioPharmX Corporation
26/08/201623:20Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)AMEX:BPMXBioPharmX Corporation
24/08/201614:00PR Newswire (US)BioPharmX Enrolls First Subject in OPAL Phase 2b Clinical Trial of BPX-01 Topical Minocycline for the Treatment of AcneAMEX:BPMXBioPharmX Corporation
22/08/201614:00PR Newswire (US)BioPharmX Announces Final Phase 2a Trial Results Find BPX-01 Reduces Facial P. Acnes by More than 90% in Four WeeksAMEX:BPMXBioPharmX Corporation
17/08/201601:43Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:BPMXBioPharmX Corporation
21/07/201614:00PR Newswire (US)BioPharmX Study Shows BPX-01 Topical Gel Delivers Minocycline Precisely to the SkinAMEX:BPMXBioPharmX Corporation
29/06/201614:00PR Newswire (US)BioPharmX Announces Positive Topline Phase 2a Clinical Trial Results for BPX-01 in Patients with Acne-Causing BacteriaAMEX:BPMXBioPharmX Corporation
14/06/201622:05PR Newswire (US)BioPharmX Corporation Reports First Quarter Financial ResultsAMEX:BPMXBioPharmX Corporation
07/06/201614:00PR Newswire (US)BioPharmX to Report First Quarter Financial Results on June 14, 2016AMEX:BPMXBioPharmX Corporation
01/06/201622:12Edgar (US Regulatory)Revised Proxy Soliciting Materials (definitive) (defr14a)AMEX:BPMXBioPharmX Corporation
31/05/201622:07Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:BPMXBioPharmX Corporation
16/05/201614:00PR Newswire (US)BioPharmX Presents at American Congress of Obstetricians and Gynecologists (ACOG) Suggesting Molecular Iodine May be Effectiv...AMEX:BPMXBioPharmX Corporation
12/05/201622:15PR Newswire (US)BioPharmX CEO Steps Down, Board Appoints Independent Director to Serve as ChairmanAMEX:BPMXBioPharmX Corporation
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:AMEX:BPMX

La tua Cronologia

BIT
P1ZG21
NLBNPIT1ZG21 20241220 35
BIT
LSIL
ETFS 2x Daily Long Silver
COIN
MINAUSD
Mina
NASDAQ
NTLA
Intellia Therapeutics
BIT
BRE
Brembo NV
NASDAQ
MIPS
LSE
0F3G
Lingotes Especiales
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network